See What HealthDay Can Do For You
Contact Us

Wearable Kidney Safe and Effective

First version of a wearable artificial kidney looks promising

FRIDAY, Dec. 14 (HealthDay News) -- A wearable artificial kidney appears to be largely safe and effective in patients with end-stage kidney failure, according to study findings published in the Dec. 15 issue of The Lancet.

Andrew Davenport, M.D., from Royal Free and University College Hospital Medical School in London, United Kingdom, and colleagues fitted eight patients with end-stage kidney failure who were on regular hemodialysis with a wearable hemodialysis device for four to eight hours. Patients were given unfractionated heparin as would be the case for standard hemodialysis.

The researchers found that the device did not lead to any adverse cardiovascular changes or changes in serum electrolytes or acid-base balance. The mean blood flow was 58.6 mL/min, the mean dialysate flow was 47.1 mL/min, the mean plasma urea clearance rate was 22.7 mL/min, and the mean plasma creatinine clearance rate was 20.7 mL/min. Two patients had clotting of the vascular access after reducing the heparin dose and the fistula needle became dislodged in one patient, but both problems were resolved.

"The wearable artificial kidney…is a first small step in the long road to wearable blood-cleansing devices," Garabed Eknoyan, M.D., from Baylor College of Medicine in Houston, writes in an accompanying editorial.

The study was funded by Xcorporeal Inc., the makers of the device, and several study contributors have disclosed financial relationships with the company.

Abstract
Full Text (subscription or payment may be required)
Editorial

Physician's Briefing

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.